Blog

The Pacific Neuroscience Institute’s state-of-the-art Neurodiagnostic Treatment Suite is complete and providing infusion therapies for a variety of neurological conditions including Multiple Sclerosis (MS) and pituitary disorders such as Pituitary Adenomas. Launched in April 2021, the facility represents another convenience for our patients where they...

A gratitude study uses beautiful videos on a mobile-based app to enhance well-being and adds to the Visual Healing® studies at Pacific Neuroscience Institute.

By Rex Hoffman, MD, Chief Medical Officer, SoCal Clinical Institutes and Chief Medical Officer, Providence Holy Cross Medical Center April 1, 2021 – I am pleased to announce that Santosh Kesari, MD, PhD, has been named regional medical director of Southern California’s Research Clinical Institute....

Nature-themed visual experience and psilocybin therapy used for treatment of alcohol use disorder SANTA MONICA, Calif., March 18, 2021— Pacific Neuroscience Institute (PNI) has launched its first psychedelic-assisted clinical trial and begun participant enrollment. The Visual Healing® study is a collaboration among PNI, award-winning filmmaker...

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells...

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

Congratulations to Tiffany Juarez, PhD, for receiving the Saint John’s Cancer Institute Q3 2020 Mission Spirit Award! Tiffany is an incredible Program Manager in the Department of Translational Neurosciences. She is an outstanding and dedicated caregiver who truly lives the spirit of our Mission and...

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...